Taconic Biosciences Cage+ colony management service aims to offer comprehensive coverage for contract breeding services.
Taconic Biosciences, a provider of drug discovery animal model solutions, announced its Cage+ product on Feb. 21, 2022. Cage+ is a holistic colony management model that is intended to offer comprehensive coverage for contract breeding services.
According to a company press release, project planning and management burden is often placed on investigators, who likely do not have the time or expertise to design and manage scaled production of complex animal models. Cage+ is meant to provide a solution to this, as it applies a holistic approach that combines standard animal breeding and husbandry elements with breeding design expertise, project-specific methodology, budget monitoring, and proactive project management and communication.
Additionally, the Cage+ program:
“Researchers should demand better from contract breeding service providers, and this view is the driving factor behind our Cage+ stewardship-based approach to colony management solutions,” said John Couse, vice-president, scientific services, Taconic Biosciences, in the press release. “With Cage+, researchers will view Taconic as an extension of their team, leveraging the collaboration of scientists and experts. Our approach allows investigators to focus their time, energy, and resources on research while trusting their custom model animal development and production to Taconic.”
Source: Taconic Biosciences
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.